Consolidated Statements of Comprehensive Loss (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Statement Of Income And Comprehensive Income [Abstract]
Net loss including noncontrolling interests	$ (20,129,284)	$ (22,414,640)	$ (5,229,725)
Other comprehensive income (loss):
Foreign currency translation adjustment	(421,345)	797,558	153,815
Comprehensive loss including noncontrolling interests	(20,550,629)	(21,617,082)	(5,075,910)
Comprehensive loss attributable to noncontrolling interests	3,048,618	3,844,800	1,177,397
Comprehensive loss attributable to Cleveland BioLabs, Inc.	$ (17,502,011)	$ (17,772,282)	$ (3,898,513)